METTL3 and colorectal carcinoma: This enhancement, in turn, inhibits the m6A modification level in 3′-UTR (1511-1515nt) of CCNE1 mRNA mediated by METTL3, further reducing the expression of cyclin E1 (CCNE1) and successfully inhibiting the development of CRC [84].